CORY HOOVER: Open Payments
NPI 1528610177 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Neuronetics, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: REXULTI, NEUROSTAR TMS THERAPY SYSTEM, AUSTEDO XR, SPRAVATO.
Industry payments across OR — which companies pay providers there.
